SERB receives EU approval for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity London, Jan. 14, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals today announced that the European Commission has granted marketing authorisation for Voraxaze® (glucarpidase) to...

Se presenta la primera evidencia de toxicidad relacionada con el metotrexato en dosis elevadas en España durante la Virtual ISPOR Europe 2021 COPENHAGUE, Dinamarca, Dec. 02, 2021 (GLOBE NEWSWIRE) -- La primera evidencia de la toxicidad relacionada con el metotrexato en dosis elevadas (HDMTX) en España se expuso hoy en la Virtual ISPOR...

First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021 COPENHAGEN, Denmark, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global...

BTG Specialty Pharmaceuticals Calls on Consumers and Retailers to Consider the Facts About Venom Extractors WEST CONSHOHOCKEN, Pa., April 20, 2021 (GLOBE NEWSWIRE) -- To prepare for snakebite season, BTG Specialty Pharmaceuticals, a maker of critical care medicines, calls on outdoor enthusiasts to throw...